GREENBROOK TMS INC (GBNH) Stock Price & Overview

NASDAQ:GBNH • CA3937043097

Current stock price

0.121 USD
-0.08 (-40.69%)
At close:
0.1153 USD
-0.01 (-4.71%)
After Hours:

The current stock price of GBNH is 0.121 USD. Today GBNH is down by -40.69%. In the past month the price decreased by -59.67%. In the past year, price decreased by -92.98%.

GBNH Key Statistics

52-Week Range0.1031 - 1.82
Current GBNH stock price positioned within its 52-week range.
1-Month Range0.1031 - 0.638
Current GBNH stock price positioned within its 1-month range.
Market Cap
5.175M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-2.41
Dividend Yield
N/A

GBNH Stock Performance

Today
-40.69%
1 Week
-41.63%
1 Month
-59.67%
3 Months
-54.11%
Longer-term
6 Months -52.57%
1 Year -92.98%
2 Years -96.20%
3 Years N/A
5 Years N/A
10 Years N/A

GBNH Stock Chart

GREENBROOK TMS INC / GBNH Daily stock chart

GBNH Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to GBNH. When comparing the yearly performance of all stocks, GBNH is a bad performer in the overall market: 98.68% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

GBNH Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to GBNH. GBNH may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

GBNH Earnings

Next Earnings DateApr 15, 2024
Last Earnings DateNov 8, 2023
PeriodQ3 / 2023
EPS Reported-$0.30
Revenue Reported
EPS Surprise -47.06%
Revenue Surprise %

GBNH Forecast & Estimates

8 analysts have analysed GBNH and the average price target is 0.66 USD. This implies a price increase of 447.93% is expected in the next year compared to the current price of 0.121.

For the next year, analysts expect an EPS growth of 58.2% and a revenue growth 6.64% for GBNH


Analysts
Analysts80
Price Target0.66 (445.45%)
EPS Next Y58.2%
Revenue Next Year6.64%

GBNH Groups

Sector & Classification

Index Membership

GBNH Financial Highlights

Over the last trailing twelve months GBNH reported a non-GAAP Earnings per Share(EPS) of -2.41. The EPS decreased by -49.69% compared to the year before.


Income Statements
Revenue(TTM)80.09M
Net Income(TTM)-68.03M
Industry RankSector Rank
PM (TTM) N/A
ROA -78.11%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%26.83%
Sales Q2Q%29.13%
EPS 1Y (TTM)-49.69%
Revenue 1Y (TTM)47.06%

GBNH Ownership

Ownership
Inst Owners2.68%
Shares42.77M
Float13.63M
Ins Owners17.86%
Short Float %N/A
Short RatioN/A

About GBNH

Company Profile

Greenbrook Tms, Inc. engages in the control and operation of a network of outpatient mental health services centers that specialize in the provision of Transcranial Magnetic Stimulation (TMS) therapy and other treatment modalities for the treatment of depression and related psychiatric services. The company is headquartered in Toronto, Ontario and currently employs 629 full-time employees. The company went IPO on 2018-11-27. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Spravato is offered to treat adults with treatment-resistant depression and depressive symptoms in adults with MDD with suicidal thoughts or actions. The firm operates a network of outpatient mental health service centers that specialize in Treatment across the United States. The company offers Treatment Centers in convenient locations to provide easy access to patients and clinicians. The firm owns and operates 133 Treatment Centers in the Commonwealths of Massachusetts, Virginia and Pennsylvania and the States of Maryland, North Carolina, Missouri, Illinois, Ohio, Texas, Connecticut, Florida, and South Carolina.

Company Info

IPO: 2018-11-27

GREENBROOK TMS INC

890 Yonge St 7th Floor

TORONTO ONTARIO M4W 3P4 CA

CEO: Bill Leonard

Employees: 629

GBNH Company Website

Phone: 14163229700

GREENBROOK TMS INC / GBNH FAQ

What does GREENBROOK TMS INC do?

Greenbrook Tms, Inc. engages in the control and operation of a network of outpatient mental health services centers that specialize in the provision of Transcranial Magnetic Stimulation (TMS) therapy and other treatment modalities for the treatment of depression and related psychiatric services. The company is headquartered in Toronto, Ontario and currently employs 629 full-time employees. The company went IPO on 2018-11-27. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Spravato is offered to treat adults with treatment-resistant depression and depressive symptoms in adults with MDD with suicidal thoughts or actions. The firm operates a network of outpatient mental health service centers that specialize in Treatment across the United States. The company offers Treatment Centers in convenient locations to provide easy access to patients and clinicians. The firm owns and operates 133 Treatment Centers in the Commonwealths of Massachusetts, Virginia and Pennsylvania and the States of Maryland, North Carolina, Missouri, Illinois, Ohio, Texas, Connecticut, Florida, and South Carolina.


Can you provide the latest stock price for GREENBROOK TMS INC?

The current stock price of GBNH is 0.121 USD. The price decreased by -40.69% in the last trading session.


Does GREENBROOK TMS INC pay dividends?

GBNH does not pay a dividend.


What is the ChartMill technical and fundamental rating of GBNH stock?

GBNH has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


Can you provide the sector and industry classification for GREENBROOK TMS INC?

GREENBROOK TMS INC (GBNH) operates in the Health Care sector and the Health Care Providers & Services industry.


What is the employee count for GBNH stock?

GREENBROOK TMS INC (GBNH) currently has 629 employees.


Who owns GREENBROOK TMS INC?

You can find the ownership structure of GREENBROOK TMS INC (GBNH) on the Ownership tab.